| TUE · NOV 17, 2026 | ![]() | ROBOTICS |
TODAY’S LEAD Plot twist: US says NVIDIA cut off the suspect chip buyer last year The US government says NVIDIA stopped selling to Megaspeed in June 2025, a month after investigators asked. READ THE LEAD STORY →Coolcaesar/Wikimedia Commons, CC BY-SA 4.0 |
| By Kim Isenberg | Forwarded? Subscribe free → |

$5B Isomorphic raised to take AI-designed drugs into human trials | $8.2B AMD's all-stock deal for Fei-Fei Li's World Labs | 825M Anthropic IPO shares, with demand far above that |
Kim Isenberg
| → | IN SHORT OpenAI wanted to own a company that can look inside its models; now it pays that company to inspect them. |
![]() Image: Isomorphic Labs Isomorphic raises $5 billion as its AI-designed drugs near human trials
Isomorphic Labs, the Alphabet drug company led by Demis Hassabis, says its AI-designed drugs are working in early tests and are heading for human trials. The company reports positive lab and animal results in its own cancer and immune-disease programs, and with partners. To take that step, it has raised $5 billion, six months after a $2.1 billion round in May. Greenoaks and Sequoia led the round, with a16z and Alphabet joining. Isomorphic did not disclose a valuation; in October, Bloomberg reported talks at $40 billion or more. | ![]() Fei-Fei Li, who now joins AMD as executive vice president and chief scientist. Image: Getty Images via TechCrunch AMD closes its World Labs deal, Fei-Fei Li joins
AMD has completed its purchase of World Labs, the startup founded by AI pioneer Fei-Fei Li. The all-stock deal was valued at about $8.2 billion when it was announced in September. World Labs builds AI models that generate interactive 3D worlds, which can also serve as training grounds for robots. Li becomes AMD's executive vice president and chief scientist, reporting to CEO Lisa Su, and her team will help shape AMD's future chips and software. |
10 Stocks at the Center of AI’s $1 Trillion Boom
AI’s growth story is much bigger than chatbots.
The market was already valued at an estimated $800 billion by late 2025, and continued adoption could push it beyond $1 trillion in the years ahead. That growth will require more data centers, computing power, software, networking and intelligent devices.
But the most obvious AI names may not be the only companies positioned to benefit.
MarketBeat’s free 10 Best AI Stocks to Own in 2026 report identifies ten publicly traded companies helping power the next phase of the AI buildout. Some are established leaders. Others occupy less obvious corners of the expanding AI ecosystem.
This free report names 10 stocks positioned to ride that wave before the rest of the market catches on.

|
| EXPORT CONTROLS |
2024 Commerce starts investigating Megaspeed | May 2025 Commerce asks NVIDIA for its sales records | June 2025 NVIDIA puts Megaspeed on its no-sell list |
| → | Commerce and Justice say NVIDIA put Megaspeed on its "no sell" list in June 2025, a month after investigators asked for its sales records. |
| → | The agencies say they spoke up to correct "inaccurate information" in recent reporting. The Justice Department now leads a criminal investigation of Megaspeed. |
| → | NVIDIA's board created a standing National Security and Export Control Oversight Committee, chaired by Suzanne Nora Johnson and backed by outside experts. |
| → | Colette Kress reports NVIDIA's third-quarter results tonight, her first as interim CEO. |


| → | WHY IT MATTERS The US government itself says NVIDIA stopped selling to Megaspeed a month after investigators asked, and it accuses NVIDIA of nothing. That is good news for NVIDIA. Its biggest political risk is its chips ending up in the wrong hands, and the new board committee is meant to stop exactly that. |
Attio is the #1 fastest-growing CRM on Brex and Ramp.
Built for the most ambitious companies in GTM, Attio is an end to end revenue platform that allows teams to run multiple plays across different revenue motions and lifecycles.
Teams at the frontier are already building on it: Granola, turbopuffer, Modal, and many many more.

EXPECT A SPEED-UP 98% | → | SEVEN TO TEN YEARS SOONER 21.6% |
| Scientists asked how much sooner AI could deliver a discovery that would take ten years | ||
| → The chart | OpenAI asked 250 scientists in its ChatGPT for Academic Researchers pilot to picture a discovery that would take ten years without AI, then say how much sooner AI could deliver it. 98% expected a speed-up. Half (50.4%) said three to six years sooner, and 21.6% said seven to ten years sooner, so within three years. Mathematicians and statisticians were the boldest: 31% picked seven to ten years. |
| → The lesson | Scientists who already use these tools in their research expect faster discoveries, not just faster paperwork. Their own time estimates in the same study point the same way: work they did with AI would have taken 1.9 times as long without it. They also keep checking: about one in three requests led to a follow-up asking ChatGPT to clarify, check or revise. |
| → The caveat | These are expectations from ChatGPT users in a study by OpenAI's own economists, not measured discoveries. The scientists named the limits AI does not fix: time or staff (51.8%) and funding (43.8%). |

| → Bottom line | OpenMind connected its humanoid robot Iris to lab-grown human brain cells, which helped it react to people's social cues. |
| → Why it matters | It shows living neurons can work inside a real robot's decision loop, a possible path to robot brains that use far less energy. |
| → What it means | Biological computing is still slow and fragile, but it has moved from the lab dish into a humanoid robot. |
94% of reads correct for the flat cultures, within 150 to 240 milliseconds | 500 trials in OpenMind's test with Iris |


| WANT MORE? |











